Search by Drug Name or NDC

    NDC 25021-0185-10 ganciclovir 50 mg/mL Details

    ganciclovir 50 mg/mL

    ganciclovir is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is GANCICLOVIR SODIUM.

    Product Information

    NDC 25021-0185
    Product ID 25021-185_696f706f-39d7-4647-a506-2ebf7b956cc1
    Associated GPIs 12200030102030
    GCN Sequence Number 078313
    GCN Sequence Number Description ganciclovir sodium VIAL 500MG/10ML INTRAVEN
    HIC3 W5A
    HIC3 Description ANTIVIRALS, GENERAL
    GCN 44623
    HICL Sequence Number 004558
    HICL Sequence Number Description GANCICLOVIR SODIUM
    Brand/Generic Generic
    Proprietary Name ganciclovir
    Proprietary Name Suffix n/a
    Non-Proprietary Name ganciclovir sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 50
    Active Ingredient Units mg/mL
    Substance Name GANCICLOVIR SODIUM
    Labeler Name Sagent Pharmaceuticals
    Pharmaceutical Class Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA207645
    Listing Certified Through 2024-12-31

    Package

    NDC 25021-0185-10 (25021018510)

    NDC Package Code 25021-185-10
    Billing NDC 25021018510
    Package 25 VIAL in 1 CARTON (25021-185-10) / 10 mL in 1 VIAL
    Marketing Start Date 2018-02-15
    NDC Exclude Flag N
    Pricing Information N/A